193 related articles for article (PubMed ID: 30995145)
1. Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records.
Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; Theuns DA; Bhagwandien RE; van Bruchem-Visser RL; Lokker IE; van der Heide A; Rietjens JA
Eur J Cardiovasc Nurs; 2019 Aug; 18(6):449-457. PubMed ID: 30995145
[TBL] [Abstract][Full Text] [Related]
2. Deactivation of Implantable Cardioverter Defibrillator in Patients With Terminal Diagnoses.
Trussler A; Alexander B; Campbell D; Alhammad N; Enriquez A; Chacko S; Garrett T; Simpson C; Redfearn D; Abdollah H; Herx L; Baranchuk A
Am J Cardiol; 2019 Oct; 124(7):1064-1068. PubMed ID: 31353003
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations.
Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D
Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823
[TBL] [Abstract][Full Text] [Related]
4. Improving implantable cardioverter defibrillator deactivation discussions in admitted patients made DNR and comfort care.
Choi DY; Wagner MP; Yum B; Jannat-Khah DP; Mazique DC; Crossman DJ; Lee JI
BMJ Open Qual; 2019; 8(4):e000730. PubMed ID: 31922034
[TBL] [Abstract][Full Text] [Related]
5. Defibrillator patients should not be denied a peaceful death.
Westerdahl AK; Sutton R; Frykman V
Int J Cardiol; 2015 Mar; 182():440-6. PubMed ID: 25597981
[TBL] [Abstract][Full Text] [Related]
6. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.
Sherazi S; McNitt S; Aktas MK; Polonsky B; Shah AH; Moss AJ; Daubert JP; Zareba W
Pacing Clin Electrophysiol; 2013 Oct; 36(10):1273-9. PubMed ID: 23731284
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
[TBL] [Abstract][Full Text] [Related]
8. Deactivation of implantable defibrillators at end of life - Can we do better?
Kinch Westerdahl A; Magnsjö J; Frykman V
Int J Cardiol; 2019 Sep; 291():57-62. PubMed ID: 30853295
[TBL] [Abstract][Full Text] [Related]
9. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
Daeschler M; Verdino RJ; Kirkpatrick JN
Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
[TBL] [Abstract][Full Text] [Related]
10. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
[TBL] [Abstract][Full Text] [Related]
11. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
[TBL] [Abstract][Full Text] [Related]
12. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
Russo JE
Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
[TBL] [Abstract][Full Text] [Related]
13. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.
Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT
Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436
[TBL] [Abstract][Full Text] [Related]
14. Discussions on Implantable Cardioverter-Defibrillator Deactivation in Patients Receiving Radiation Therapy: A Missed Opportunity.
Salum E; Turner S; Syeda A; Singh SM
Can J Cardiol; 2021 Feb; 37(2):347-349. PubMed ID: 32810469
[TBL] [Abstract][Full Text] [Related]
15. Deactivation of implantable defibrillators at the end of life - A register-based study of ICD-deactivation at home and the impact of palliative care.
Höijer CJ; Johnson MJ
Int J Cardiol; 2023 Sep; 386():91-94. PubMed ID: 37263357
[TBL] [Abstract][Full Text] [Related]
16. Deactivation of implantable cardioverter defibrillator in Japanese patients with end-stage heart failure.
Nakazawa M; Suzuki T; Shiga T; Suzuki A; Hagiwara N
J Arrhythm; 2021 Feb; 37(1):196-202. PubMed ID: 33664903
[TBL] [Abstract][Full Text] [Related]
17. Quality dying: An approach to ICD deactivation in the hospital setting.
Turner S; Torabi S; Stilos K
Am J Hosp Palliat Care; 2020 Sep; 37(9):664-668. PubMed ID: 32126793
[TBL] [Abstract][Full Text] [Related]
18. 'You can't start a car when there's no petrol left': a qualitative study of patient, family and clinician perspectives on implantable cardioverter defibrillator deactivation.
Standing H; Thomson RG; Flynn D; Hughes J; Joyce K; Lobban T; Lord S; Matlock DD; McComb JM; Paes P; Wilkinson C; Exley C
BMJ Open; 2021 Jul; 11(7):e048024. PubMed ID: 34230020
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
[TBL] [Abstract][Full Text] [Related]
20. Patient and Professional Factors That Impact the Perceived Likelihood and Confidence of Healthcare Professionals to Discuss Implantable Cardioverter Defibrillator Deactivation in Advanced Heart Failure: Results From an International Factorial Survey.
Hill L; McIlfatrick S; Taylor BJ; Jaarsma T; Moser D; Slater P; McAloon T; Dixon L; Donnelly P; Stromberg A; Fitzsimons D
J Cardiovasc Nurs; 2018; 33(6):527-535. PubMed ID: 29727378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
